Your browser doesn't support javascript.
loading
Mitochondrial Stress Induces an HRI-eIF2α Pathway Protective for Cardiomyopathy.
Zhu, Siting; Nguyen, Anh; Pang, Jing; Zhao, Jun; Chen, Ze'e; Liang, Zhengyu; Gu, Yusu; Huynh, Helen; Bao, Yutong; Lee, Sharon; Kluger, Yuval; Ouyang, Kunfu; Evans, Sylvia M; Fang, Xi.
Afiliação
  • Zhu S; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Nguyen A; Department of Cardiovascular Surgery, Peking University Shenzhen Hospital, School of Chemical Biology and Biotechnology, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, China (S.Z., Z.C., K.O.).
  • Pang J; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Zhao J; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Chen Z; Department of Pathology, Yale School of Medicine, New Haven, CT (J.Z., Y.K.).
  • Liang Z; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Gu Y; Department of Cardiovascular Surgery, Peking University Shenzhen Hospital, School of Chemical Biology and Biotechnology, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, China (S.Z., Z.C., K.O.).
  • Huynh H; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Bao Y; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Lee S; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Kluger Y; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Ouyang K; Department of Medicine (S.Z., A.N., J.P., Z.C., Z.L., Y.G., H.H., Y.B., S.L., S.M.E., X.F.), University of California San Diego, La Jolla.
  • Evans SM; Department of Pathology, Yale School of Medicine, New Haven, CT (J.Z., Y.K.).
  • Fang X; Department of Cardiovascular Surgery, Peking University Shenzhen Hospital, School of Chemical Biology and Biotechnology, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, China (S.Z., Z.C., K.O.).
Circulation ; 146(13): 1028-1031, 2022 09 27.
Article em En | MEDLINE | ID: mdl-36154620
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Iniciação 2 em Eucariotos / Cardiomiopatias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Iniciação 2 em Eucariotos / Cardiomiopatias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article